Treatment of Citrobacter UTI in Pediatrics
For pediatric urinary tract infections caused by Citrobacter species, treat with empiric broad-spectrum antibiotics based on local resistance patterns and adjust according to culture sensitivities, using the same approach as for other gram-negative enteric organisms. 1, 2
Initial Empiric Antibiotic Selection
For Febrile/Toxic-Appearing Children or Those Unable to Tolerate Oral Medications
Parenteral therapy is indicated for children who appear toxic, cannot retain oral intake, or when compliance is uncertain. 1
Age-Specific Parenteral Regimens:
8-21 days old: Ampicillin IV/IM (150 mg/kg/day divided every 8 hours) PLUS either ceftazidime IV/IM (150 mg/kg/day divided every 8 hours) OR gentamicin IV/IM (4 mg/kg/dose every 24 hours) 3
22-28 days old: Ceftriaxone IV/IM (50 mg/kg/dose every 24 hours) 3
29-60 days and older: Ceftriaxone IV/IM (50 mg/kg/dose every 24 hours) 3
Alternative parenteral options (all ages): Cefotaxime 150 mg/kg/day divided every 6-8 hours, tobramycin 5 mg/kg/day divided every 8 hours, or piperacillin 300 mg/kg/day divided every 6-8 hours 1
For Well-Appearing Children Who Can Tolerate Oral Medications
Oral therapy is equally efficacious to parenteral therapy for most children with UTI. 1
Oral Treatment Options:
Cephalosporins: Cefixime 8 mg/kg/day in 1 dose, cefpodoxime 10 mg/kg/day in 2 doses, cefprozil 30 mg/kg/day in 2 doses, cefuroxime axetil 20-30 mg/kg/day in 2 doses, or cephalexin 50-100 mg/kg/day in 4 doses 1
Amoxicillin-clavulanate: 20-40 mg/kg/day in 3 doses 1
Trimethoprim-sulfamethoxazole: 6-12 mg/kg trimethoprim and 30-60 mg/kg sulfamethoxazole per day in 2 doses (only if local resistance rates are acceptable) 1
Critical Treatment Considerations
Local Resistance Patterns Are Essential
Base antibiotic selection on local antimicrobial susceptibility patterns, particularly for trimethoprim-sulfamethoxazole and cephalexin, as there is substantial geographic variability. 1 Citrobacter species can develop resistance to commonly used antibiotics, making knowledge of local resistance patterns crucial 2, 4
Avoid Nitrofurantoin in Febrile UTI
Do not use nitrofurantoin for febrile infants with UTIs, as it does not achieve therapeutic concentrations in the bloodstream and may be insufficient to treat pyelonephritis or urosepsis. 1
Adjust Based on Culture Results
Always adjust the initial empiric regimen according to sensitivity testing of the isolated uropathogen. 1
Duration of Therapy
The total course of therapy should be 7 to 14 days, regardless of whether treatment is initiated orally or parenterally. 1
- Courses of 1-3 days are inferior and should not be used 1
- Children initially treated parenterally should transition to oral therapy once they demonstrate clinical improvement (generally within 24-48 hours) and can retain oral fluids and medications 1
Special Populations at Higher Risk
Citrobacter UTIs occur more frequently in children with underlying medical conditions, including urinary tract/renal anomalies, neurologic impairment, or nosocomial exposure. 2 These patients warrant closer monitoring and may require more aggressive initial therapy 2, 5
Imaging Recommendations
All febrile infants with UTIs should undergo renal and bladder ultrasonography (RBUS). 1
- For children with severe illness or inadequate clinical improvement, perform RBUS within the first 2 days to identify complications such as renal/perirenal abscesses or pyonephrosis 1
- For children demonstrating substantial clinical improvement, imaging can be delayed and does not need to occur during acute infection 1
Common Pitfalls to Avoid
- Do not delay treatment while awaiting culture results in symptomatic children; prompt antibiotic therapy within 48 hours of fever onset reduces risk of renal scarring 6, 7
- Do not assume all Citrobacter infections are benign; while uncommon, they can cause serious complications including bacteremia and abscess formation, particularly in immunocompromised patients 2, 4, 5
- Do not use empiric narrow-spectrum agents without knowledge of local Citrobacter susceptibility patterns, as resistance is increasing 4, 8